• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through November 2012, and other …

Guidelines (Task Force) directs this effort by develo**, updating, and revising practice
guidelines for cardiovascular diseases and procedures. Experts in the subject under …

Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and
mortality. Despite its prevalence, significant practice variation continues to permeate clinical …

Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

This document on cardiovascular infection, including infective endocarditis, is the first in the
American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the …